{
    "root": "8ff1d6e9-b7ac-4b4f-af40-b1fb8a0809aa",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Glucagon",
    "value": "20230228",
    "ingredients": [],
    "indications": "glucagon injection antihypoglycemic agent gastrointestinal motility inhibitor indicated : \u2022 treatment severe hypoglycemia pediatric adult patients diabetes . ( 1.1 ) \u2022 diagnostic aid radiologic examinations temporarily inhibit movement gastrointestinal tract adult patients . ( 1.2 )",
    "contraindications": "adult pediatric patients treat severe hypoglycemia ( 2.2 ) \u2022 adults pediatric patients weighing 20 kg : \u25aa recommended 1 mg ( 1 ml ) injected subcutaneously intramuscularly upper arm , thigh , buttocks , intravenously . \u25aa response 15 minutes , additional 1 mg dose ( 1 ml ) may administered waiting emergency assistance . \u2022 pediatric patients weighing less 20 kg : \u25aa recommended 0.5 mg ( 0.5 ml ) dose equivalent 20 mcg/kg 30 mcg/kg injected subcutaneously intramuscularly upper arm , thigh , buttocks , intravenously . \u25aa response 15 minutes , additional 0.5 mg dose ( 0.5 ml ) may administered waiting emergency assistance . important instructions using glucagon injection treat severe hypoglycemia ( 2.1 ) \u2022 glucagon injection subcutaneous , intramuscular , intravenous injection . administer intravenously medical supervision . \u2022 full prescribing information instructions adults using glucagon injection diagnostic aid ( 2.4 ) \u2022 doses required relaxation stomach , duodenum , small bowel , depend onset duration effect required examination . \u2022 dose relaxation duodenum small bowel 0.25 mg 0.5 mg given intravenously 1 mg given intramuscularly . \u2022 stomach 0.5 mg intravenous 2 mg intramuscular doses recommended . \u2022 colon , recommended 2 mg dose administered intramuscularly approximately 10 minutes prior procedure . \u2022 full prescribing information instructions ( 2.3 )",
    "warningsAndPrecautions": null,
    "adverseReactions": "glucagon injection contraindicated patients : \u2022pheochromocytoma risk substantial increase blood pressure [ warning ( 5.1 ) ] \u2022insulinoma risk hypoglycemia [ warning ( 5.2 ) ] \u2022known hypersensitivity glucagon excipients glucagon injection . allergic reported glucagon include anaphylactic shock breathing difficulties hypotension [ warning ( 5.3 ) ] \u2022glucagonoma used diagnostic aid risk hypoglycemia [ ( 5.8 ) ]",
    "indications_original": "Glucagon for Injection is an antihypoglycemic agent and a gastrointestinal motility inhibitor indicated: \u2022 for the treatment of severe hypoglycemia in pediatric and adult patients with diabetes. ( 1.1 ) \u2022 as a diagnostic aid for use during radiologic examinations to temporarily inhibit movement of the gastrointestinal tract in adult patients. ( 1.2 )",
    "contraindications_original": "Dosage in adult and pediatric patients to treat severe hypoglycemia ( 2.2 ) \u2022 Adults and Pediatric Patients Weighing 20 kg or More: \u25aa The recommended dosage is 1 mg (1 mL) injected subcutaneously or intramuscularly into the upper arm, thigh, or buttocks, or intravenously. \u25aa If there has been no response after 15 minutes, an additional 1 mg dose (1 mL) may be administered while waiting for emergency assistance. \u2022 Pediatric Patients Weighing Less Than 20 kg: \u25aa The recommended dosage is 0.5 mg (0.5 mL) or dose equivalent to 20 mcg/kg to 30 mcg/kg injected subcutaneously or intramuscularly into the upper arm, thigh, or buttocks, or intravenously. \u25aa If there has been no response after 15 minutes, an additional 0.5 mg dose (0.5 mL) may be administered while waiting for emergency assistance. Important Administration Instructions for Using Glucagon for Injection to Treat Severe Hypoglycemia ( 2.1 ) \u2022 Glucagon for Injection is for subcutaneous, intramuscular, or intravenous injection. Administer intravenously ONLY under medical supervision. \u2022 See the Full Prescribing Information for administration instructions Dosage in Adults for Using Glucagon for Injection as a Diagnostic Aid ( 2.4 ) \u2022 Doses required for relaxation of the stomach, duodenum, and small bowel, depend on the onset and duration of effect required for the examination. \u2022 The dose for relaxation of the duodenum and small bowel is 0.25 mg to 0.5 mg given intravenously or 1 mg given intramuscularly. \u2022 For the stomach 0.5 mg intravenous or 2 mg intramuscular doses are recommended. \u2022 For the colon, it is recommended that a 2 mg dose be administered intramuscularly approximately 10 minutes prior to the procedure. \u2022 See the Full Prescribing Information for administration instructions ( 2.3 )",
    "adverseReactions_original": "Glucagon for Injection is contraindicated in patients with: \n                  \n                     \n                        \u2022Pheochromocytoma because of the risk of substantial increase in blood pressure [see Warning and Precautions (5.1)] \n                     \n                     \n                        \u2022Insulinoma because of the risk of hypoglycemia [see Warning and Precautions (5.2)] \n                     \n                     \n                        \u2022Known hypersensitivity to glucagon or any of the excipients in Glucagon for Injection. Allergic reactions have been reported with glucagon and include anaphylactic shock with breathing difficulties and hypotension [see Warning and Precautions (5.3)] \n                     \n                     \n                        \u2022Glucagonoma when used as a diagnostic aid because of the risk of hypoglycemia [see Warnings and Precautions (5.8)]"
}